Other

Equity Securities, FV-NI, Unrealized Gains (Losses)

MetLife Equity Securities, FV-NI, Unrealized Gains (Losses) decreased by 13.7% to $2.83B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.8%, from $2.16B to $2.83B. Over 4 years (FY 2021 to FY 2025), Equity Securities, FV-NI, Unrealized Gains (Losses) shows an upward trend with a 9.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026
Metric ID: other_equity_and_trading_securities_fvni_unrealized_gain_a2076b

Historical Data

18 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.26B$1.65B$712.00M$277.00M$562.00M$879.00M$1.12B$1.01B$1.59B$2.02B$2.09B$2.00B$2.39B$2.16B$2.70B$3.19B$3.27B$2.83B
QoQ Change—-27.0%-56.8%-61.1%+102.9%+56.4%+27.8%-9.8%+56.9%+27.0%+3.7%-4.4%+19.3%-9.5%+24.8%+18.4%+2.6%-13.7%
YoY Change————-75.1%-46.7%+57.7%+265.7%+182.7%+129.6%+86.4%+97.5%+50.3%+7.0%+28.8%+59.5%+37.1%+30.8%
Range$277.00M – $3.27B
CAGR+5.4%
Avg YoY Growth+65.1%
Median YoY Growth+54.0%

Frequently Asked Questions

What is MetLife's equity securities, fv-ni, unrealized gains (losses)?
MetLife (MET) reported equity securities, fv-ni, unrealized gains (losses) of $2.83B in Q1 2026.
How has MetLife's equity securities, fv-ni, unrealized gains (losses) changed year-over-year?
MetLife's equity securities, fv-ni, unrealized gains (losses) increased by 30.8% year-over-year, from $2.16B to $2.83B.
What is the long-term trend for MetLife's equity securities, fv-ni, unrealized gains (losses)?
Over 4 years (2021 to 2025), MetLife's equity securities, fv-ni, unrealized gains (losses) has grown at a 9.8% compound annual growth rate (CAGR), from $2.26B to $3.27B.